Cargando…
Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve eyes of 9 patients presented at the Department of Opht...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801805/ https://www.ncbi.nlm.nih.gov/pubmed/35111790 http://dx.doi.org/10.3389/fmed.2021.823346 |
_version_ | 1784642545018470400 |
---|---|
author | Pang, Kunpeng Pan, Lijie Guo, Hui Wu, Xinyi |
author_facet | Pang, Kunpeng Pan, Lijie Guo, Hui Wu, Xinyi |
author_sort | Pang, Kunpeng |
collection | PubMed |
description | The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve eyes of 9 patients presented at the Department of Ophthalmology, Qilu Hospital of Shandong University from March to August 2021 with ocular complaints following COVID-19 vaccination. The main inclusion criterion was the development of ocular symptoms within 14 days after receiving a dose of an inactivated COVID-19 vaccine. The mean (SD) age was 44.7 ± 16.5 years (range, 19–78 years), among which seven (77.8%) cases were women. The mean time of ocular adverse events was 7.1 days (range, 1–14 days) after receiving the inactivated COVID-19 vaccine. One patient was diagnosed with choroiditis, 1 with uveitis, 4 with keratitis, 1 with scleritis, 1 with acute retinal necrosis, and 1 with iridocyclitis. Although the causal relationship between vaccines and ocular adverse events cannot be established from this case series report, physicians should pay attention to the ocular adverse reactions following the COVID-19 vaccine administration. |
format | Online Article Text |
id | pubmed-8801805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88018052022-02-01 Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China Pang, Kunpeng Pan, Lijie Guo, Hui Wu, Xinyi Front Med (Lausanne) Medicine The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve eyes of 9 patients presented at the Department of Ophthalmology, Qilu Hospital of Shandong University from March to August 2021 with ocular complaints following COVID-19 vaccination. The main inclusion criterion was the development of ocular symptoms within 14 days after receiving a dose of an inactivated COVID-19 vaccine. The mean (SD) age was 44.7 ± 16.5 years (range, 19–78 years), among which seven (77.8%) cases were women. The mean time of ocular adverse events was 7.1 days (range, 1–14 days) after receiving the inactivated COVID-19 vaccine. One patient was diagnosed with choroiditis, 1 with uveitis, 4 with keratitis, 1 with scleritis, 1 with acute retinal necrosis, and 1 with iridocyclitis. Although the causal relationship between vaccines and ocular adverse events cannot be established from this case series report, physicians should pay attention to the ocular adverse reactions following the COVID-19 vaccine administration. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8801805/ /pubmed/35111790 http://dx.doi.org/10.3389/fmed.2021.823346 Text en Copyright © 2022 Pang, Pan, Guo and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Pang, Kunpeng Pan, Lijie Guo, Hui Wu, Xinyi Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China |
title | Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China |
title_full | Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China |
title_fullStr | Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China |
title_full_unstemmed | Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China |
title_short | Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China |
title_sort | case report: associated ocular adverse reactions with inactivated covid-19 vaccine in china |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801805/ https://www.ncbi.nlm.nih.gov/pubmed/35111790 http://dx.doi.org/10.3389/fmed.2021.823346 |
work_keys_str_mv | AT pangkunpeng casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina AT panlijie casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina AT guohui casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina AT wuxinyi casereportassociatedocularadversereactionswithinactivatedcovid19vaccineinchina |